Literature DB >> 1304367

Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase.

G J Barton1, C P Ponting, G Spraggon, C Finnis, D Sleep.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1304367      PMCID： PMC2142224          DOI： 10.1002/pro.5560010514

Source DB:  PubMed          Journal:  Protein Sci        ISSN： 0961-8368            Impact factor:   6.725


× No keyword cloud information.
  16 in total

1.  Three-dimensional structure of thymidine phosphorylase from Escherichia coli at 2.8 A resolution.

Authors:  M R Walter; W J Cook; L B Cole; S A Short; G W Koszalka; T A Krenitsky; S E Ealick
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

2.  Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells.

Authors:  C H Heldin; A Wasteson; B Westermark
Journal:  Exp Cell Res       Date:  1977-10-15       Impact factor: 3.905

3.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

4.  Thymidine phosphorylase from Escherichia coli.

Authors:  M Schwartz
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Characterization and partial purification of an endothelial cell growth factor from human platelets.

Authors:  G L King; S Buchwald
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Catabolism of thymidine in human blood platelets: purification and properties of thymidine phosphorylase.

Authors:  C Desgranges; G Razaka; M Rabaud; H Bricaud
Journal:  Biochim Biophys Acta       Date:  1981-07-27

7.  Identification of common molecular subsequences.

Authors:  T F Smith; M S Waterman
Journal:  J Mol Biol       Date:  1981-03-25       Impact factor: 5.469

8.  Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture.

Authors:  K Usuki; N E Heldin; K Miyazono; F Ishikawa; F Takaku; B Westermark; C H Heldin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

10.  Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors.

Authors:  A Yoshimura; Y Kuwazuru; T Furukawa; H Yoshida; K Yamada; S Akiyama
Journal:  Biochim Biophys Acta       Date:  1990-04-23
View more
  13 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

2.  Interferons upregulate thymidine phosphorylase expression via JAK-STAT-dependent transcriptional activation and mRNA stabilization in human glioblastoma cells.

Authors:  Yongxue Yao; Toshihiko Kubota; Kazufumi Sato; Hiroaki Takeuchi; Ryuhei Kitai; Shigeru Matsukawa
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

3.  Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.

Authors:  D P Stevenson; S R Milligan; W P Collins
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  Unexpected sequence similarity between nucleosidases and phosphoribosyltransferases of different specificity.

Authors:  A R Mushegian; E V Koonin
Journal:  Protein Sci       Date:  1994-07       Impact factor: 6.725

5.  Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.

Authors:  D P Stevenson; W P Collins; F Farzaneh; K Hata; K Miyazaki
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

6.  Thymidine phosphorylase is angiogenic and promotes tumor growth.

Authors:  A Moghaddam; H T Zhang; T P Fan; D E Hu; V C Lees; H Turley; S B Fox; K C Gatter; A L Harris; R Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

7.  Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; K J O'Byrne; M Comley; R M Whitehouse; D C Talbot; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 8.  Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.

Authors:  L Griffiths; I J Stratford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.

Authors:  S B Fox; M Westwood; A Moghaddam; M Comley; H Turley; R M Whitehouse; R Bicknell; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  The cytosol activity of thymidine phosphorylase in endometrial cancer.

Authors:  Elzbieta Miszczak-Zaborska; Robert Kubiak; Andrzej Bieńkiewicz; Jacek Bartkowiak
Journal:  J Exp Clin Cancer Res       Date:  2008-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.